Company Filing History:
1 out of 30 
1 out of 20 Years Active: 2022
Title: Liugen Li - Innovator in Pharmaceutical Chemistry
Introduction
Liugen Li is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Liugen Li holds a patent for spirocyclic tetrahydroquinazolines. This patent provides compounds represented by Formula I, wherein R, A, E, L, Q, Z, and other variables are defined in the specification. These compounds serve as KRAS inhibitors, making them useful in the treatment of cancer and other diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Liugen Li has worked with notable companies in the pharmaceutical industry, including Ascentage Pharma (Suzhou) Co., Ltd. and Ascentage Pharma Group Corp Limited. His work has focused on innovative solutions to complex medical challenges.
Collaborations
Liugen Li has collaborated with esteemed colleagues such as Chao Li and Guozhi Tang, contributing to advancements in their shared field of expertise.
Conclusion
Liugen Li's innovative work in pharmaceutical chemistry, particularly with KRAS inhibitors, showcases his commitment to advancing medical science. His contributions are paving the way for new treatments in cancer therapy.